July 18 (UPI) -- Researchers say they have identified a protein -- tyrosine phosphatase receptor type Z, or PTPRZ, -- as a drug target for patients with glioblastoma.
Glioblastoma has been classified by the World Health Organization as the highest grade glioma, a type of brain tumor that is difficult to treat with the median survival rate of patients with glioblastoma is 14 months.